RXi Pharmaceuticals Is Still On Track With Its Sd-rxRNA Technology Despite Recent Sell-Off By: TalkMarkets January 21, 2015 at 00:18 AM EST RXi's recent results in hypertrophic scars provides an excellent buying opportunity for long term investors. Read More >> Related Stocks: Regeneron Pharmaceuticals Roche Holding AG Basel American Depositary Shares